Literature DB >> 30527230

The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.

Megan L Ludwig1, Aditi Kulkarni2, Andrew C Birkeland2, Nicole L Michmerhuizen3, Susan K Foltin2, Jacqueline E Mann4, Rebecca C Hoesli2, Samantha N Devenport1, Brittany M Jewell2, Andrew G Shuman5, Matthew E Spector6, Thomas E Carey7, Hui Jiang8, J Chad Brenner9.   

Abstract

OBJECTIVES: We sought to describe the genetic complexity of 14 UM-SCC oral cavity cancer cell lines that have remained uncharacterized despite being used as model systems for decades.
MATERIALS AND METHODS: We performed exome sequencing on 14 oral cavity UM-SCC cell lines and denote the mutational profile of each line. We used a SNP array to profile the multiple copy number variations of each cell line and use immunoblotting to compare alterations to protein expression of commonly amplified genes (EGFR, PIK3CA, etc.). RNA sequencing was performed to characterize the expression of genes with copy number alterations.
RESULTS: The cell lines displayed a highly complex network of genetic aberrations that was consistent with alterations identified in the HNSCC TCGA project including PIK3CA amplification, CDKN2A deletion, as well as TP53 and CASP8 mutations, enabling genetic stratification of each cell line in the panel. Copy number FISH and spectral karyotyping analysis demonstrate that cell lines retain chromosomal heterogeneity.
CONCLUSIONS: Collectively, we developed an important resource for future oral cavity HNSCC cell line studies and highlight the complexity of genomic aberrations in cell lines.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell Lines; Exome; HNSCC; Oral cancer; UM-SCC

Mesh:

Substances:

Year:  2018        PMID: 30527230      PMCID: PMC6349383          DOI: 10.1016/j.oraloncology.2018.10.031

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  46 in total

1.  Differential compensation mechanisms define resistance to PI3K inhibitors in PIK3CA amplified HNSCC.

Authors:  Nicole L Michmerhuizen; Elizabeth Leonard; Aditi Kulkarni; J Chad Brenner
Journal:  Otorhinolaryngol Head Neck Surg       Date:  2016-06-07

Review 2.  The potential for tumor suppressor gene therapy in head and neck cancer.

Authors:  Andrew C Birkeland; Megan L Ludwig; Matthew E Spector; J Chad Brenner
Journal:  Discov Med       Date:  2016-01       Impact factor: 2.970

Review 3.  Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

Authors:  M Giefing; M Wierzbicka; K Szyfter; J C Brenner; B J Braakhuis; R H Brakenhoff; C R Bradford; J A Sorensen; A Rinaldo; J P Rodrigo; R P Takes; A Ferlito
Journal:  Eur J Cancer       Date:  2016-02-04       Impact factor: 9.162

4.  The mutational landscape of head and neck squamous cell carcinoma.

Authors:  Nicolas Stransky; Ann Marie Egloff; Aaron D Tward; Aleksandar D Kostic; Kristian Cibulskis; Andrey Sivachenko; Gregory V Kryukov; Michael S Lawrence; Carrie Sougnez; Aaron McKenna; Erica Shefler; Alex H Ramos; Petar Stojanov; Scott L Carter; Douglas Voet; Maria L Cortés; Daniel Auclair; Michael F Berger; Gordon Saksena; Candace Guiducci; Robert C Onofrio; Melissa Parkin; Marjorie Romkes; Joel L Weissfeld; Raja R Seethala; Lin Wang; Claudia Rangel-Escareño; Juan Carlos Fernandez-Lopez; Alfredo Hidalgo-Miranda; Jorge Melendez-Zajgla; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz; Todd R Golub; Levi A Garraway; Jennifer R Grandis
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

5.  In vitro effects of tamoxifen on UM-SCC head and neck cancer cell lines: correlation with the estrogen and progesterone receptor content.

Authors:  R Grenman; E Virolainen; A Shapira; T Carey
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

6.  Consistent chromosome abnormalities in squamous cell carcinoma of the vulva.

Authors:  M J Worsham; D L Van Dyke; S E Grenman; R Grenman; M P Hopkins; J A Roberts; K M Gasser; D R Schwartz; T E Carey
Journal:  Genes Chromosomes Cancer       Date:  1991-11       Impact factor: 5.006

7.  Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.

Authors:  Brittny N Tillman; Megan Yanik; Andrew C Birkeland; Chia-Jen Liu; Daniel H Hovelson; Andi K Cani; Nallasivam Palanisamy; Shannon Carskadon; Thomas E Carey; Carol R Bradford; Scott A Tomlins; Jonathan B McHugh; Matthew E Spector; J Chad Brenner
Journal:  Head Neck       Date:  2016-02-05       Impact factor: 3.147

8.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

9.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

10.  Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.

Authors:  Megan L Ludwig; Andrew C Birkeland; Rebecca Hoesli; Paul Swiecicki; Matthew E Spector; J Chad Brenner
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248

View more
  13 in total

1.  Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma.

Authors:  Nicole L Michmerhuizen; Elizabeth Leonard; Chloe Matovina; Micah Harris; Gabrielle Herbst; Aditi Kulkarni; Jingyi Zhai; Hui Jiang; Thomas E Carey; J Chad Brenner
Journal:  Mol Pharmacol       Date:  2019-03-11       Impact factor: 4.436

2.  Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.

Authors:  Molly E Heft Neal; Andrew C Birkeland; Apurva D Bhangale; Jingyi Zhai; Aditi Kulkarni; Susan K Foltin; Brittany M Jewell; Megan L Ludwig; Lisa Pinatti; Hui Jiang; Jonathan B McHugh; Lawence Marentette; Erin L McKean; J Chad Brenner
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

Review 3.  Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.

Authors:  Joanna Kałafut; Arkadiusz Czerwonka; Alinda Anameriç; Alicja Przybyszewska-Podstawka; Julia O Misiorek; Adolfo Rivero-Müller; Matthias Nees
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

4.  A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma.

Authors:  Paul L Swiecicki; Greg Durm; Emily Bellile; Apurva Bhangale; J Chad Brenner; Francis P Worden
Journal:  Invest New Drugs       Date:  2020-01-24       Impact factor: 3.651

5.  The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.

Authors:  Jacqueline E Mann; Aditi Kulkarni; Andrew C Birkeland; Judy Kafelghazal; Julia Eisenberg; Brittany M Jewell; Megan L Ludwig; Matthew E Spector; Hui Jiang; Thomas E Carey; J Chad Brenner
Journal:  Head Neck       Date:  2019-05-15       Impact factor: 3.821

6.  Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma.

Authors:  M E Heft Neal; E Gensterblum-Miller; A D Bhangale; A Kulkarni; J Zhai; J Smith; C Brummel; S K Foltin; D Thomas; H Jiang; J B McHugh; J C Brenner
Journal:  Oral Oncol       Date:  2021-04-04       Impact factor: 5.972

Review 7.  Protecting Tumors by Preventing Human Papilloma Virus Antigen Presentation: Insights from Emerging Bioinformatics Algorithms.

Authors:  Elizabeth Gensterblum-Miller; J Chad Brenner
Journal:  Cancers (Basel)       Date:  2019-10-12       Impact factor: 6.639

Review 8.  PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis.

Authors:  Ali Alqahtani; Hazem S K Ayesh; Hafez Halawani
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

9.  Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.

Authors:  Kiyoshi Misawa; Atsushi Imai; Hirotaka Matsui; Akinori Kanai; Yuki Misawa; Daiki Mochizuki; Masato Mima; Satoshi Yamada; Tomoya Kurokawa; Takuya Nakagawa; Hiroyuki Mineta
Journal:  Oncogene       Date:  2020-05-15       Impact factor: 9.867

10.  Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.

Authors:  Johannes Routila; Karri Suvila; Reidar Grénman; Ilmo Leivo; Jukka Westermarck; Sami Ventelä
Journal:  BMC Cancer       Date:  2021-07-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.